Liraglutide CAS:204656-20-2 Mugadziri weMugadziri
Liraglutide imhando itsva yemushonga unoderedza shuga mumuviri unoshanda neAMP-activated protein kinase, zvichiwedzera insulin sensitivity. Haingogumiri pakuita kuti munhu anzwe hypoglycemia, asiwo ine mabasa ekuderedza uremu, kuderedza BP, uye kuvandudza huwandu hwemafuta muropa. Liraglutide, mushonga unoshanda seglucagon-like peptide-1 (GLP-1) receptor agonist, inoderedza kubuda kweropa mudumbu, inowedzera kuguta, uye inoderedza kudya kwemurwere, ukuwo ichideredza chishuwo cheuropi chekudya uye ichibvumira muviri kuti uderedze uremu. Kuwedzera kwesimba rekushandisa kunoita basa mukuderedza uremu; inodzivirira chiropa kubva pakugadzira glucose yakawandisa uye inosimudzira pancreas kugadzira insulin yakawanda kuderedza shuga muropa; pamusoro pezvo, liraglutide inewo mabhenefiti emwoyo uye dziviriro yeitsvo.
| Kuumbwa | C172H265N43O51 |
| Kuyedza | 99% |
| Chitarisiko | Upfu chena |
| Nhamba yeCAS | 204656-20-2 |
| Kurongedza | 25KG |
| Hupenyu hweSherufu | makore maviri |
| Kuchengetera | Chengeta munzvimbo inotonhorera uye yakaoma |
| Chitupa | ISO. |








